Doxepin, a tricyclic antidepressant, binds to normal, intact astroglial cells in cultures and inhibits the isoproterenol-induced increase in cyclic AMP production.
Doxepin binds to intact astrocytes in primary cultures. The binding is competitively displaceable by excess cold doxepin and it is pronounced (Bmax = 27 nmol/mg protein) but the affinity is rather low (KD = 30 microM). The binding is inhibited by other antidepressants (amitriptyline, desipramine, tranylcypromine, iprindole) and propranolol but not by isoproterenol. Nevertheless, doxepin counteracts effectively the increase in the production of cyclic AMP evoked by isoproterenol.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001253:Astrocytes / Q000378:metabolism*; D001665:Binding Sites; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000096:biosynthesis*; D004316:Doxepin / Q000378:metabolism* / Q000494:pharmacology; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D051379:Mice; D011433:Propranolol / Q000494:pharmacology
D000928:Antidepressive Agents; D004316:Doxepin; D011433:Propranolol; D000242:Cyclic AMP; D007545:Isoproterenol